Trials / Completed
CompletedNCT03984071
The Predictive Value of eGFR for Adverse Cardiovascular Events in Patients With STEMI
The Predictive Value of Estimated Glomerular Filtration Rate (eGFR) for Adverse Cardiovascular Events in the Hospital in Patients With ST-segment Elevation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3 (actual)
- Sponsor
- Dongying Zhang · Academic / Other
- Sex
- All
- Age
- 24 Years – 93 Years
- Healthy volunteers
- Accepted
Summary
Estimated glomerular filtration rate(eGFR) is significantly reduced in patients with ST-segment elevation myocardial infarction (STEMI). The aim of this study is to research that the incidence of adverse cardiovascular events (MACE) in patients with ST-segment elevation myocardial infarction is significantly higher when the glomerular filtration rate below a certain value.
Detailed description
The investigators retrospectively analyzed the clinical data of 1157 patients with ST-segment elevation myocardial infarction. In-hospital adverse cardiovascular events (MACE) was defined as: cardiac arrest, cardiac rupture, malignant arrhythmia, and cardiac death. All the patients were divided into 3 groups according to the patient's estimated glomerular filtration rate(eGFR) (eGFR≥90ml/min/1.73m2; 90ml/min/1.73m2\>eGFR≥60ml/min/1.73m2; eGFR\<60ml/min /1.73m2). COX regression analysis and K-M survival curves are used to calculate the correlation between eGFR and in-hospital MACE.
Conditions
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2018-02-28
- Completion
- 2018-02-28
- First posted
- 2019-06-12
- Last updated
- 2019-06-12
Source: ClinicalTrials.gov record NCT03984071. Inclusion in this directory is not an endorsement.